• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of cmrPermissionsJournals.ASM.orgJournalCMR ArticleJournal InfoAuthorsReviewers
Clin Microbiol Rev. Oct 1995; 8(4): 462–478.
PMCID: PMC172871

New and emerging yeast pathogens.


The most common yeast species that act as agents of human disease are Candida albicans, Candida tropicalis, Candida glabrata, Candida parapsilosis, and Cryptococcus neoformans. The incidence of infections by other yeasts has increased during the past decade. The most evident emerging pathogens are Malassezia furfur, Trichosporon beigelii, Rhodotorula species, Hansenula anomala, Candida lusitaniae, and Candida krusei. Organisms once considered environmental contaminants or only industrially important, such as Candida utilis and Candida lipolytica, have now been implicated as agents of fungemia, onychomycosis, and systemic disease. The unusual yeasts primarily infect immunocompromised patients, newborns, and the elderly. The role of central venous catheter removal and antifungal therapy in patient management is controversial. The antibiograms of the unusual yeasts range from resistant to the most recent azoles and amphotericin B to highly susceptible to all antifungal agents. Current routine methods for yeast identification may be insufficient to identify the unusual yeasts within 2 days after isolation. The recognition of unusual yeasts as agents of sometimes life-threatening infection and their unpredictable antifungal susceptibilities increase the burden on the clinical mycology laboratory to pursue complete species identification and MIC determinations. Given the current and evolving medical practices for management of seriously ill patients, further evaluations of the clinically important data about these yeasts are needed.

Full Text

The Full Text of this article is available as a PDF (783K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ahearn DG, McGlohn MS. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. J Clin Microbiol. 1984 Mar;19(3):412–416. [PMC free article] [PubMed]
  • Al-Hedaithy SS. The medically important yeasts present in clinical specimens. Ann Saudi Med. 1992 Jan;12(1):57–62. [PubMed]
  • Alsina A, Mason M, Uphoff RA, Riggsby WS, Becker JM, Murphy D. Catheter-associated Candida utilis fungemia in a patient with acquired immunodeficiency syndrome: species verification with a molecular probe. J Clin Microbiol. 1988 Apr;26(4):621–624. [PMC free article] [PubMed]
  • Alter SJ, Farley J. Development of Hansenula anomala infection in a child receiving fluconazole therapy. Pediatr Infect Dis J. 1994 Feb;13(2):158–159. [PubMed]
  • Anaissie E, Bodey GP. Nosocomial fungal infections. Old problems and new challenges. Infect Dis Clin North Am. 1989 Dec;3(4):867–882. [PubMed]
  • Anaissie E, Bodey GP, Kantarjian H, Ro J, Vartivarian SE, Hopfer R, Hoy J, Rolston K. New spectrum of fungal infections in patients with cancer. Rev Infect Dis. 1989 May-Jun;11(3):369–378. [PubMed]
  • Anaissie E, Gokaslan A, Hachem R, Rubin R, Griffin G, Robinson R, Sobel J, Bodey G. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis. 1992 Nov;15(5):781–787. [PubMed]
  • Anaissie E, Hachem R, K-Tin-U C, Stephens LC, Bodey GP. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity. Infect Immun. 1993 Apr;61(4):1268–1271. [PMC free article] [PubMed]
  • Anaissie E, Pinczowski H. Invasive candidiasis during granulocytopenia. Recent Results Cancer Res. 1993;132:137–145. [PubMed]
  • Arisoy ES, Correa A, Seilheimer DK, Kaplan SL. Candida rugosa central venous catheter infection in a child. Pediatr Infect Dis J. 1993 Nov;12(11):961–963. [PubMed]
  • Badenhorst L, Botha PL, van Rensburg MN. The incidence of hospital fungal infections--yeast fungaemia. S Afr Med J. 1991 Mar 16;79(6):302–303. [PubMed]
  • Baker JG, Nadler HL, Forgacs P, Kurtz SR. Candida lusitaniae: a new opportunistic pathogen of the urinary tract. Diagn Microbiol Infect Dis. 1984 Apr;2(2):145–149. [PubMed]
  • Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, Edwards JR, Tolson J, Henderson T, Martone WJ. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med. 1991 Sep 16;91(3B):86S–89S. [PubMed]
  • Beck-Sagué C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993 May;167(5):1247–1251. [PubMed]
  • States B, Segal S. Levels of gamma-glutamyltranspeptidase in cultured skin fibroblasts from cystinotics and normals. Life Sci. 1980 Nov 24;27(21):1985–1990. [PubMed]
  • Bergman AG, Kauffman CA. Dermatitis due to Sporobolomyces infection. Arch Dermatol. 1984 Aug;120(8):1059–1060. [PubMed]
  • Bisbe J, Vilardell J, Valls M, Moreno A, Brancos M, Andreu J. Transient fungemia and Candida arthritis due to Candida zeylanoides. Eur J Clin Microbiol. 1987 Dec;6(6):668–669. [PubMed]
  • Blinkhorn RJ, Adelstein D, Spagnuolo PJ. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol. 1989 Feb;27(2):236–240. [PMC free article] [PubMed]
  • Bodey GP. What's new in fungal infection in leukemic patients. Leuk Lymphoma. 1993;11 (Suppl 2):127–135. [PubMed]
  • Booth LV, Collins AL, Lowes JA, Radford M. Skin rash associated with Candida guilliermondii. Med Pediatr Oncol. 1988;16(4):295–296. [PubMed]
  • Borg-von Zepelin M, Eiffert H, Kann M, Rüchel R. Changes in the spectrum of fungal isolates: results from clinical specimens gathered in 1987/88 compared with those in 1991/92 in the University Hospital Göttingen, Germany. Mycoses. 1993 Jul-Aug;36(7-8):247–253. [PubMed]
  • Bougnoux ME, Gueho E, Potocka AC. Resolutive Candida utilis fungemia in a nonneutropenic patient. J Clin Microbiol. 1993 Jun;31(6):1644–1645. [PMC free article] [PubMed]
  • Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother. 1990 Feb;34(2):183–188. [PMC free article] [PubMed]
  • Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol. 1994 Feb;32(2):452–456. [PMC free article] [PubMed]
  • Braun DK, Kauffman CA. Rhodotorula fungaemia: a life-threatening complication of indwelling central venous catheters. Mycoses. 1992 Nov-Dec;35(11-12):305–308. [PubMed]
  • Carmody TJ, Kane KK. Torulopsis (Candida) glabrata endocarditis involving a bovine pericardial xenograft heart valve. Heart Lung. 1986 Jan;15(1):40–42. [PubMed]
  • Chakrabarti A, Chander J, Kasturi P, Panigrahi D. Candidaemia: a 10-year study in an Indian teaching hospital. Mycoses. 1992 Jan-Feb;35(1-2):47–51. [PubMed]
  • Chertow GM, Marcantonio ER, Wells RG. Saccharomyces cerevisiae empyema in a patient with esophago-pleural fistula complicating variceal sclerotherapy. Chest. 1991 Jun;99(6):1518–1519. [PubMed]
  • Cimolai N, Gill MJ, Church D. Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagn Microbiol Infect Dis. 1987 Oct;8(2):113–117. [PubMed]
  • Crozier WJ. Two cases of onychomycosis due to Candida zeylanoides. Australas J Dermatol. 1993;34(1):23–25. [PubMed]
  • D'Antonio D, Fioritoni G, Iacone A, Betti S, Fazii P, Dell'Isola M, Di Gianfilippo R, Di Silverio A, Ubezio S, Zeccara C, et al. Hepatosplenic infection caused by Candida parapsilosis in patients with acute leukemia. Mycoses. 1992 Nov-Dec;35(11-12):311–313. [PubMed]
  • D'Antonio D, Piccolomini R, Fioritoni G, Iacone A, Betti S, Fazii P, Mazzoni A. Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia. J Clin Microbiol. 1994 Jan;32(1):224–227. [PMC free article] [PubMed]
  • de Gentile L, Bouchara JP, Cimon B, Chabasse D. Candida ciferrii: clinical and microbiological features of an emerging pathogen. Mycoses. 1991 Mar-Apr;34(3-4):125–128. [PubMed]
  • Dick JD, Rosengard BR, Merz WG, Stuart RK, Hutchins GM, Saral R. Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. Ann Intern Med. 1985 Jan;102(1):67–68. [PubMed]
  • Dickensheets DL. Hansenula anomala infection. Rev Infect Dis. 1989 May-Jun;11(3):507–508. [PubMed]
  • Dubé MP, Heseltine PN, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis. 1994 Jan;18(1):77–82. [PubMed]
  • Dyess DL, Garrison RN, Fry DE. Candida sepsis. Implications of polymicrobial blood-borne infection. Arch Surg. 1985 Mar;120(3):345–348. [PubMed]
  • Eisenberg ES, Alpert BE, Weiss RA, Mittman N, Soeiro R. Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Am J Med. 1983 Aug;75(2):349–352. [PubMed]
  • Eisenberg ES, Leviton I, Soeiro R. Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature. Rev Infect Dis. 1986 May-Jun;8(3):309–321. [PubMed]
  • Eng RH, Drehmel R, Smith SM, Goldstein EJ. Saccharomyces cerevisiae infections in man. Sabouraudia. 1984;22(5):403–407. [PubMed]
  • Fisher DJ, Christy C, Spafford P, Maniscalco WM, Hardy DJ, Graman PS. Neonatal Trichosporon beigelii infection: report of a cluster of cases in a neonatal intensive care unit. Pediatr Infect Dis J. 1993 Feb;12(2):149–155. [PubMed]
  • Furman RM, Ahearn DG. Candida ciferrii and Candida chiropterorum isolated from clinical specimens. J Clin Microbiol. 1983 Nov;18(5):1252–1255. [PMC free article] [PubMed]
  • Gabal MA. Antifungal activity of ketoconazole with emphasis on zoophilic fungal pathogens. Am J Vet Res. 1986 Jun;47(6):1229–1234. [PubMed]
  • Gargeya IB, Pruitt WR, Meyer SA, Ahearn DG. Candida haemulonii from clinical specimens in the USA. J Med Vet Mycol. 1991;29(5):335–338. [PubMed]
  • Gelfand MS. Candida tropicalis. Infect Control Hosp Epidemiol. 1989 Jun;10(6):280–283. [PubMed]
  • Glick C, Graves GR, Feldman S. Torulopsis glabrata in the neonate: an emerging fungal pathogen. South Med J. 1993 Aug;86(8):969–970. [PubMed]
  • Gold WL, Vellend H, Salit IE, Campbell I, Summerbell R, Rinaldi M, Simor AE. Successful treatment of systemic and local infections due to Exophiala species. Clin Infect Dis. 1994 Aug;19(2):339–341. [PubMed]
  • Goldman M, Pottage JC, Jr, Weaver DC. Candida krusei fungemia. Report of 4 cases and review of the literature. Medicine (Baltimore) 1993 May;72(3):143–150. [PubMed]
  • Guého E, Improvisi L, de Hoog GS, Dupont B. Trichosporon on humans: a practical account. Mycoses. 1994 Jan-Feb;37(1-2):3–10. [PubMed]
  • Gugnani HC, Okafor BC, Nzelibe F, Njoku-Obi AN. Etiological agents of otomycosis in Nigeria. Mycoses. 1989 May;32(5):224–229. [PubMed]
  • Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis. 1987 Sep-Oct;9(5):1006–1012. [PubMed]
  • Hamilton-Miller JM. The effect of pH and of temperature on the stability and bioactivity of nystatin and amphotericin B. J Pharm Pharmacol. 1973 May;25(5):401–407. [PubMed]
  • Haron E, Anaissie E, Dumphy F, McCredie K, Fainstein V. Hansenula anomala fungemia. Rev Infect Dis. 1988 Nov-Dec;10(6):1182–1186. [PubMed]
  • Hector RF. Compounds active against cell walls of medically important fungi. Clin Microbiol Rev. 1993 Jan;6(1):1–21. [PMC free article] [PubMed]
  • Heinic GS, Greenspan D, MacPhail LA, Greenspan JS. Oral Geotrichum candidum infection associated with HIV infection. A case report. Oral Surg Oral Med Oral Pathol. 1992 Jun;73(6):726–728. [PubMed]
  • Heney C, Greeff M, Davis V. Hickman catheter-related protothecal algaemia in an immunocompromised child. J Infect Dis. 1991 Apr;163(4):930–931. [PubMed]
  • Hilmarsdottir I, Coutellier A, Elbaz J, Klein JM, Datry A, Guého E, Herson S. A French case of laboratory-acquired disseminated Penicillium marneffei infection in a patient with AIDS. Clin Infect Dis. 1994 Aug;19(2):357–358. [PubMed]
  • Hirasaki S, Ijichi T, Fujita N, Araki S, Gotoh H, Nakagawa M. Fungemia caused by Hansenula anomala: successful treatment with fluconazole. Intern Med. 1992 May;31(5):622–624. [PubMed]
  • Hiruma M, Kawada A, Ohata H, Ohnishi Y, Takahashi H, Yamazaki M, Ishibashi A, Hatsuse K, Kakihara M, Yoshida M. Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses. 1993 Jan-Feb;36(1-2):1–7. [PubMed]
  • Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis. 1985 Sep-Oct;7(5):646–655. [PubMed]
  • Kaminski ZC, Kapila R, Sharer LR, Kloser P, Kaufman L. Meningitis due to Prototheca wickerhamii in a patient with AIDS. Clin Infect Dis. 1992 Oct;15(4):704–706. [PubMed]
  • Karabinis A, Hill C, Leclercq B, Tancrède C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol. 1988 Mar;26(3):429–432. [PMC free article] [PubMed]
  • Katzenstein D. Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome. Arthritis Rheum. 1985 Dec;28(12):1421–1424. [PubMed]
  • Kiehn TE, Gorey E, Brown AE, Edwards FF, Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis. 1992 Apr;14(4):841–846. [PubMed]
  • Klein AS, Tortora GT, Malowitz R, Greene WH. Hansenula anomala: a new fungal pathogen. Two case reports and a review of the literature. Arch Intern Med. 1988 May;148(5):1210–1213. [PubMed]
  • Klotz SA. Malassezia furfur. Infect Dis Clin North Am. 1989 Mar;3(1):53–64. [PubMed]
  • Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis. 1989 May-Jun;11(3):379–390. [PubMed]
  • Krogh P, Holmstrup P, Thorn JJ, Vedtofte P, Pindborg JJ. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol. 1987 Jan;63(1):48–54. [PubMed]
  • Lehmann PF, Wu LC, Pruitt WR, Meyer SA, Ahearn DG. Unrelatedness of groups of yeasts within the Candida haemulonii complex. J Clin Microbiol. 1993 Jul;31(7):1683–1687. [PMC free article] [PubMed]
  • Levenson D, Pfaller MA, Smith MA, Hollis R, Gerarden T, Tucci CB, Isenberg HD. Candida zeylanoides: another opportunistic yeast. J Clin Microbiol. 1991 Aug;29(8):1689–1692. [PMC free article] [PubMed]
  • Manian FA, Brischetto MJ. Pulmonary infection due to Exophiala jeanselmei: successful treatment with ketoconazole. Clin Infect Dis. 1993 Mar;16(3):445–446. [PubMed]
  • Marcon MJ, Powell DA. Human infections due to Malassezia spp. Clin Microbiol Rev. 1992 Apr;5(2):101–119. [PMC free article] [PubMed]
  • Martín E, Parras P, Lozano MC. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. Chemotherapy. 1992;38(5):335–339. [PubMed]
  • Martino P, Venditti M, Micozzi A, Morace G, Polonelli L, Mantovani MP, Petti MC, Burgio VL, Santini C, Serra P, et al. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis. 1990 Jul-Aug;12(4):570–582. [PubMed]
  • McGinnis MR, Ajello L, Beneke ES, Drouhet E, Goodman NL, Halde CJ, Haley LD, Kane J, Land GA, Padhye AA, et al. Taxonomic and nomenclatural evaluation of the genera Candida and Torulopsis. J Clin Microbiol. 1984 Oct;20(4):813–814. [PMC free article] [PubMed]
  • Medoff G, Brajtburg J, Kobayashi GS, Bolard J. Antifungal agents useful in therapy of systemic fungal infections. Annu Rev Pharmacol Toxicol. 1983;23:303–330. [PubMed]
  • Merz WG. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol. 1984 Dec;20(6):1194–1195. [PMC free article] [PubMed]
  • Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis. 1992 Mar;14 (Suppl 1):S120–S125. [PubMed]
  • Middelhoven WJ, De Kievit H, Biesbroek AL. Yeast species utilizing uric acid, adenine, n-alkylamines or diamines as sole source of carbon and energy. Antonie Van Leeuwenhoek. 1985;51(3):289–301. [PubMed]
  • Mirza SH. Disseminated Trichosporon beigelii infection causing skin lesions in a renal transplant patient. J Infect. 1993 Jul;27(1):67–70. [PubMed]
  • Molina TC, Mishra SK, Pierson DL. A microfermentation test for the rapid identification of yeasts. J Med Vet Mycol. 1992;30(4):323–326. [PubMed]
  • Morgan MA, Wilkowske CJ, Roberts GD. Candida pseudotropicalis fungemia and invasive disease in an immunocompromised patient. J Clin Microbiol. 1984 Nov;20(5):1006–1007. [PMC free article] [PubMed]
  • Morris JT, Beckius M, McAllister CK. Sporobolomyces infection in an AIDS patient. J Infect Dis. 1991 Sep;164(3):623–624. [PubMed]
  • Morris JT, McAllister CK. Fungemia due to Torulopsis glabrata. South Med J. 1993 Mar;86(3):356–357. [PubMed]
  • Morrison AJ, Jr, Freer CV, Searcy MA, Landry SM, Wenzel RP. Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Infect Control. 1986 Nov;7(11):550–553. [PubMed]
  • Muñoz P, Garcia Leoni ME, Berenguer J, Bernaldo de Quiros JC, Bouza E. Catheter-related fungemia by Hansenula anomala. Arch Intern Med. 1989 Mar;149(3):709–713. [PubMed]
  • Murphy N, Buchanan CR, Damjanovic V, Whitaker R, Hart CA, Cooke RW. Infection and colonisation of neonates by Hansenula anomala. Lancet. 1986 Feb 8;1(8476):291–293. [PubMed]
  • Neumeister B, Rockemann M, Marre R. Fungaemia due to Candida pelliculosa in a case of acute pancreatitis. Mycoses. 1992 Nov-Dec;35(11-12):309–310. [PubMed]
  • Nielsen H, Stenderup J, Bruun B, Ladefoged J. Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1990 Jul;28(7):1664–1665. [PMC free article] [PubMed]
  • Nohinek B, Zee-Cheng CS, Barnes WG, Dall L, Gibbs HR. Infective endocarditis of a bicuspid aortic valve caused by Hansenula anomala. Am J Med. 1987 Jan;82(1):165–168. [PubMed]
  • Oriol A, Ribera JM, Arnal J, Milla F, Batlle M, Feliu E. Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome. Am J Hematol. 1993 Aug;43(4):325–326. [PubMed]
  • Pappagianis D, Collins MS, Hector R, Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother. 1979 Aug;16(2):123–126. [PMC free article] [PubMed]
  • Pautler KB, Padhye AA, Ajello L. Imported penicilliosis marneffei in the United States: report of a second human infection. Sabouraudia. 1984;22(5):433–438. [PubMed]
  • Pfaller MA. Infection control: opportunistic fungal infections--the increasing importance of Candida species. Infect Control Hosp Epidemiol. 1989 Jun;10(6):270–273. [PubMed]
  • Pfaller MA, Barry AL. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol. 1994 Aug;32(8):1992–1996. [PMC free article] [PubMed]
  • Plazas J, Portilla J, Boix V, Pérez-Mateo M. Sporobolomyces salmonicolor lymphadenitis in an AIDS patient. Pathogen or passenger? AIDS. 1994 Mar;8(3):387–388. [PubMed]
  • Polacheck I, Salkin IF, Kitzes-Cohen R, Raz R. Endocarditis caused by Blastoschizomyces capitatus and taxonomic review of the genus. J Clin Microbiol. 1992 Sep;30(9):2318–2322. [PMC free article] [PubMed]
  • Pospisil L. The significance of Candida pulcherrima findings in human clinical specimens. Mycoses. 1989 Nov;32(11):581–583. [PubMed]
  • Price MF, LaRocco MT, Gentry LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother. 1994 Jun;38(6):1422–1424. [PMC free article] [PubMed]
  • Rao NA, Nerenberg AV, Forster DJ. Torulopsis candida (Candida famata) endophthalmitis simulating Propionibacterium acnes syndrome. Arch Ophthalmol. 1991 Dec;109(12):1718–1721. [PubMed]
  • Regli P, Blancard A, Goudard M, Moulin-Traffort J, Sarzier JM, Quilici M. Evaluation de la sensibilité in vitro au fluconazole de différentes espèces de levures rencontrées en pathologie. Pathol Biol (Paris) 1992 May;40(5):500–506. [PubMed]
  • Reinhardt JF, Ruane PJ, Walker LJ, George WL. Intravenous catheter-associated fungemia due to Candida rugosa. J Clin Microbiol. 1985 Dec;22(6):1056–1057. [PMC free article] [PubMed]
  • Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med. 1994 Nov 17;331(20):1325–1330. [PubMed]
  • Rex JH, Pfaller MA, Barry AL, Nelson PW, Webb CD. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Antimicrob Agents Chemother. 1995 Jan;39(1):40–44. [PMC free article] [PubMed]
  • Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis. 1991 Mar-Apr;13(2):211–215. [PubMed]
  • Rinaldi MG. Emerging opportunists. Infect Dis Clin North Am. 1989 Mar;3(1):65–76. [PubMed]
  • Salesa R, Burgos A, Fernandez-Mazarrasa C, Quindós G, Pontón J. Transient fungaemia due to Candida pelliculosa in a patient with AIDS. Mycoses. 1991 Jul-Aug;34(7-8):327–329. [PubMed]
  • Samonis G, Bafaloukos D. Fungal infections in cancer patients: an escalating problem. In Vivo. 1992 Mar-Apr;6(2):183–193. [PubMed]
  • Sanchez V, Vazquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol. 1992 Nov;30(11):3005–3008. [PMC free article] [PubMed]
  • Sanchez V, Vazquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med. 1993 Jun;94(6):577–582. [PubMed]
  • Sandhu DK, Sandhu RS, Misra VC. Isolation of Candida viswanathii from cerebrospinal fluid. Sabouraudia. 1976 Nov;14(3):251–254. [PubMed]
  • Sands M, Poppel D, Brown R. Peritonitis due to Prototheca wickerhamii in a patient undergoing chronic ambulatory peritoneal dialysis. Rev Infect Dis. 1991 May-Jun;13(3):376–378. [PubMed]
  • Seidenfeld SM, Cooper BH, Smith JW, Luby JP, Mackowiak PA. Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species. J Infect Dis. 1983 Jan;147(1):116–119. [PubMed]
  • Sethi N, Mandell W. Saccharomyces fungemia in a patient with AIDS. N Y State J Med. 1988 May;88(5):278–279. [PubMed]
  • Sinnott JT, 4th, Cullison JP, Sweeney MP. Candida (Torulopsis) glabrata. Infect Control. 1987 Aug;8(8):334–336. [PubMed]
  • Sobel JD, Vazquez J, Lynch M, Meriwether C, Zervos MJ. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy. Clin Infect Dis. 1993 Jan;16(1):93–99. [PubMed]
  • Solomon SL, Khabbaz RF, Parker RH, Anderson RL, Geraghty MA, Furman RM, Martone WJ. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis. 1984 Jan;149(1):98–102. [PubMed]
  • Stellbrink HJ, Albrecht H, Fenske S, Koperski K. Candida krusei sepsis in HIV infection. AIDS. 1992 Jul;6(7):746–748. [PubMed]
  • St-Germain G, Laverdière M. Torulopsis candida, a new opportunistic pathogen. J Clin Microbiol. 1986 Nov;24(5):884–885. [PMC free article] [PubMed]
  • Strausbaugh LJ, Sewell DL, Ward TT, Pfaller MA, Heitzman T, Tjoelker R. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol. 1994 Sep;32(9):2299–2300. [PMC free article] [PubMed]
  • Sudduth EJ, Crumbley AJ, 3rd, Farrar WE. Phaeohyphomycosis due to Exophiala species: clinical spectrum of disease in humans. Clin Infect Dis. 1992 Oct;15(4):639–644. [PubMed]
  • Sugar AM, Stevens DA. Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature. Cancer. 1985 Jul 15;56(2):318–320. [PubMed]
  • Supparatpinyo K, Chiewchanvit S, Hirunsri P, Uthammachai C, Nelson KE, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992 Apr;14(4):871–874. [PubMed]
  • Supparatpinyo K, Sirisanthana T. Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection. Clin Infect Dis. 1994 Feb;18(2):246–247. [PubMed]
  • Takamiya H, Vogt A, Batsford S, Kuttin ES, Müller J. Further studies on the immunoelectronmicroscopic localization of polysaccharide antigens on ultra-thin sections of Candida albicans. Mykosen. 1985 Jan;28(1):17–32. [PubMed]
  • Teglia O, Schoch PE, Cunha BA. Malassezia furfur infections. Infect Control Hosp Epidemiol. 1991 Nov;12(11):676–681. [PubMed]
  • Ujhelyi MR, Raasch RH, van der Horst CM, Mattern WD. Treatment of peritonitis due to Curvularia and Trichosporon with amphotericin B. Rev Infect Dis. 1990 Jul-Aug;12(4):621–627. [PubMed]
  • Walsh TJ. Trichosporonosis. Infect Dis Clin North Am. 1989 Mar;3(1):43–52. [PubMed]
  • Walsh TJ, Melcher GP, Lee JW, Pizzo PA. Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis and treatment. Curr Top Med Mycol. 1993;5:79–113. [PubMed]
  • Walsh TJ, Melcher GP, Rinaldi MG, Lecciones J, McGough DA, Kelly P, Lee J, Callender D, Rubin M, Pizzo PA. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol. 1990 Jul;28(7):1616–1622. [PMC free article] [PubMed]
  • Walsh TJ, Salkin IF, Dixon DM, Hurd NJ. Clinical, microbiological, and experimental animal studies of Candida lipolytica. J Clin Microbiol. 1989 May;27(5):927–931. [PMC free article] [PubMed]
  • Weems JJ., Jr Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis. 1992 Mar;14(3):756–766. [PubMed]
  • Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med. 1988 Dec;148(12):2642–2645. [PubMed]
  • Wehrspann P, Füllbrandt U. Fallbericht über eine aus einer Blutkultur isolierte Yarrowia lipolytica (Wickerham et al.) van der Walt & von Arx. Mykosen. 1985 May;28(5):217–222. [PubMed]
  • Wickerham LJ, Burton KA. Carbon Assimilation Tests for the Classification of Yeasts. J Bacteriol. 1948 Sep;56(3):363–371. [PMC free article] [PubMed]
  • Wickes BL, Hicks JB, Merz WG, Kwon-Chung KJ. The molecular analysis of synonymy among medically important yeasts within the genus Candida. J Gen Microbiol. 1992 May;138(5):901–907. [PubMed]
  • Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991 Oct 31;325(18):1274–1277. [PubMed]
  • Yamaguchi H, Uchida K. [In vitro susceptibility to fluconazole of fungal strains freshly isolated from child patients with deep-seated mycoses]. Jpn J Antibiot. 1993 Aug;46(8):647–653. [PubMed]
  • Yinnon AM, Woodin KA, Powell KR. Candida lusitaniae infection in the newborn: case report and review of the literature. Pediatr Infect Dis J. 1992 Oct;11(10):878–880. [PubMed]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...